References
- Gisselbrecht C, Gaulard P, Lapage E, Coiffier B, Brière J, Haioun C, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92: 76–82
- Schetelig J, Fetscher S, Reichle A, Berdel W E, Bequin Y, Brunet S, et al. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica 2003; 88: 1272–1278
- Rodrìguez J, Conde E, Gutìerrez A, Arranz R, Gandarillas M, Leon A, et al. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience. Eur J Haematol 2007; 78: 290–296
- Advani R, Warnke R, Sikic B I, Horning S. Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol 1997; 8: 601–603
- Strupp C, Aivado M, Germing U, Gattermann N, Haas R. Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports. Leuk Lymphoma 2003; 43: 133–137
- Dogan A, Ngu L S, Ng S H, Cervi P L. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia 2005; 19: 873–875
- Damaj G, Bouabdallah R, Vey N, Bilger K, Mohty M, Gastaut J A. Single-agent thalidomide induces response in T-cell lymphoma. Eur J Haematol 2005; 74: 169–171
- Ramasamy K, Lim Z, Pagliuca A, Salisbury J R, Mufti G J, Devereux S. Successful treatment of angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone. Haematologica 2006; 91: S26–S27
- Kyriakou C, Canals C, Goldstone A, Caballero D, Metzner B, Kobbe G, et al. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008; 26: 218–224